Catalyst Wire Dossier Catalyst Wire Dossier

Inovelon

rufinamide · Eisai GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inovelon, covering 2025-04-15 to 2025-04-15. Get the full timeline:

Most recent: EMA Authorised: Inovelon (rufinamide) — Eisai GmbH

See pricing